147 related articles for article (PubMed ID: 28881818)
1. 20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer.
Li J; Lu J; Ye Z; Han X; Zheng X; Hou H; Chen W; Li X; Zhao L
Oncotarget; 2017 Aug; 8(32):53375-53386. PubMed ID: 28881818
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
[TBL] [Abstract][Full Text] [Related]
3. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside 20(S)-Rg3 targets HIF-1α to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells.
Liu T; Zhao L; Zhang Y; Chen W; Liu D; Hou H; Ding L; Li X
PLoS One; 2014; 9(9):e103887. PubMed ID: 25197976
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside 20(S)‑Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells.
Li J; Liu T; Zhao L; Chen W; Hou H; Ye Z; Li X
Int J Oncol; 2015 Feb; 46(2):775-81. PubMed ID: 25405516
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells.
Lu J; Chen H; He F; You Y; Feng Z; Chen W; Li X; Zhao L
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1455-1463. PubMed ID: 32271958
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer.
Zheng X; Chen W; Hou H; Li J; Li H; Sun X; Zhao L; Li X
Biomed Pharmacother; 2017 Jan; 85():620-626. PubMed ID: 27899249
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25.
Liu D; Liu T; Teng Y; Chen W; Zhao L; Li X
Exp Ther Med; 2017 Oct; 14(4):2895-2902. PubMed ID: 28928801
[TBL] [Abstract][Full Text] [Related]
12. 20(S)-Rg3 upregulates FDFT1 via reducing miR-4425 to inhibit ovarian cancer progression.
Lu J; Zhou Y; Zheng X; Chen L; Tuo X; Chen H; Xue M; Chen Q; Chen W; Li X; Zhao L
Arch Biochem Biophys; 2020 Oct; 693():108569. PubMed ID: 32877662
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signals.
Liu T; Zhao L; Hou H; Ding L; Chen W; Li X
Tumour Biol; 2017 May; 39(5):1010428317692225. PubMed ID: 28459376
[TBL] [Abstract][Full Text] [Related]
14. Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells.
Zhang S; Pei M; Li Z; Li H; Liu Y; Li J
Cancer Sci; 2018 Sep; 109(9):2734-2745. PubMed ID: 29993160
[TBL] [Abstract][Full Text] [Related]
15. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
17. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNA-520h in 20(R)-ginsenoside-Rg3-mediated angiosuppression.
Keung MH; Chan LS; Kwok HH; Wong RN; Yue PY
J Ginseng Res; 2016 Apr; 40(2):151-9. PubMed ID: 27158236
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.
Zhou J; Xie M; Shi Y; Luo B; Gong G; Li J; Wang J; Zhao W; Zi Y; Wu X; Wen J
Oncol Rep; 2015 Jul; 34(1):111-20. PubMed ID: 25954928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
